Advertisement

Serotonin pp 727-737 | Cite as

Tryptophan in the Treatment of Depression

  • Simon N. Young
  • Guy Chouinard
  • Lawrence Annable
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 133)

Abstract

The reports by Coppen et al. (1963) and by Pare (1963), that tryptophan was capable of potentiating the antidepressant action of monoamine oxidase inhibitors, were followed by the claim of Coppen et al. (1967) that tryptophan, given alone was as effective as electroconvulsive therapy in the treatment of depression. These initial encouraging reports have been followed by more than 20 other papers in the literature, which have reached a wide variety of conclusions on the efficacy of tryptophan as an antidepressant. Even reviews on this subject reveal no consensus (Poitou and Boulu, 1977; Wirz-Justice, 1977; Murphy et al., 1978; Cooper, 1979). The purpose of this paper is to discuss some of the factors that will affect the response of depressed patients to tryptophan, and to suggest how it may be used effectively as an antidepressant.

Keywords

Therapeutic Window Monoamine Oxidase Inhibitor Bipolar Patient Electroconvulsive Therapy Antidepressant Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Awazi, N., and Guldberg, H.C., 1978, On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum, Naunyn-Schmiedeber’s Arch. Pharmacol., 303: 63.CrossRefGoogle Scholar
  2. Ayuso Gutierrez, J.L., and López-Ibor Alino, J.J., 1971, Tryptophan and an MAGI (nialamide) in the treatment of depression: a double blind study, Int. Pharmacopsychiat., 6: 92.Google Scholar
  3. Badawy, A.A.-B., and Evans, M., 1975, Tryptophan plus a pyrrolase inhibitor for depression, Lancet, ii: 869.CrossRefGoogle Scholar
  4. Carlsson, A., and Lindqvist, M., 1978, Dependence of 5HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain, Naunyn-Schmiedeber’s Arch. Pharmacol., 303: 157.CrossRefGoogle Scholar
  5. Carroll, B.J., 1971, Monoamine precursors in the treatment of depression, Clin. Pharmacol. Ther., 12: 743.PubMedGoogle Scholar
  6. Chouinard, G., Annable, L., Young, S.N., and Sourkes, T.L., 1978a, A controlled study of tryptophan-benserazide in schizophrenia, Commun. Psychopharmacol., 2: 21.PubMedGoogle Scholar
  7. Chouinard, G., Young, S.N., Annable, L., Sourkes, T.L., and Kiriakos, R.Z., 1978b, Tryptophan-nicotinamide combination in the treatment of newly admitted depressed patients, Commun. Psychopharmacol., 2: 311.PubMedGoogle Scholar
  8. Chouinard, G., Young, S.N., Annable, L., and Sourkes, T.L., 1979, Tryptophan-nicotinamide, imipramine and their combination in depression, Acta Psychiat. Scand., 59: 395PubMedCrossRefGoogle Scholar
  9. Cooper, A.J., 1979, Tryptophan antidepressant ‘physiological sedative’: fact or fancy?, Psychopharmacol., 61: 97.CrossRefGoogle Scholar
  10. Coppen, A., Shaw, D.M., and Farrell, J.P., 1963, Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan, Lancet, i: 79.CrossRefGoogle Scholar
  11. Coppen, A., Shaw, D.M., Herzberg, B., and Maggs, R., 1967, Tryptophan in the treatment of depression, Lancet, ii: 1178.CrossRefGoogle Scholar
  12. Coppen, A., Whybrow, P.C., Noguera, R., Maggs, R., and Prange, A.J., 1972, The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine, Arch. Gen. Psychiat., 26: 234.PubMedCrossRefGoogle Scholar
  13. Coppen, A., 1976, Treatment of unipolar depression, Lancet, 1: 90.PubMedCrossRefGoogle Scholar
  14. d’Elia, G., Lehmann, J., and Raotma, H., 1977, Evaluation of the combination of tryptophan and ECT in the treatment of depression: clinical analysis, Acta Psychiat. Scand., 56: 303.PubMedCrossRefGoogle Scholar
  15. Farkas, T., Dunner, D.L., and Fieve, R.R., 1976, L-Tryptophan in depression, Biol. Psychiat., 11: 295.PubMedGoogle Scholar
  16. Gallager, D.W., and Aghajanian, G.K., 1976, Inhibition of firing of raphe neurons by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro4–4602, Neuropharmacol., 15: 149.CrossRefGoogle Scholar
  17. Glassman, A.H., and Platman, S.R., 1969, Potentiation of a monoamine-oxidase inhibitor by tryptophan, J. Psychiat. Res., 7: 83.Google Scholar
  18. Green, A.R., and Grahame-Smith, D.G., 1976, Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine, Nature, 260: 487.PubMedCrossRefGoogle Scholar
  19. Green, A.R., and Grahame-Smith, D.G., 1978, Processes regulating the functional activity of brain 5-hydroxytryptamine: results of animal experimentation and their relevance to the understanding and treatment of depression, Pharmakopsychiat., 11: 3.CrossRefGoogle Scholar
  20. Haigler, H.J., and Aghajanian, G.K., 1977, Serotonin receptors in the brain, Fed. Proc., 36: 2159.PubMedGoogle Scholar
  21. Joseph, M.H., and Risby, D., 1975, The determination of kynurenine in plasma, Clin. Chim. Acta, 63: 197.PubMedCrossRefGoogle Scholar
  22. Joseph, M.H., Young, S.N., and Curzon, G., 1976, The metabolism of a tryptophan load in rat brain and liver: the influence of hydrocortisone and allopurinol, Biochem. Pharmacol., 25: 2599.PubMedCrossRefGoogle Scholar
  23. Kaplan, N.O., Goldin, A., Humphreys, S.R., Ciotti, M.M., and Stolzenbach, F.E., 1956, Pyridine nucleotide synthesis in the mouse, J. Biol. Chem., 219: 287.Google Scholar
  24. Kirkegaard, C., Moller, S.E., and Bjorum, N., 1978, Addition of L-tryptophan to electroconvulsive. treatment in endogenous depression: a double-blind study, Acta Psychiat. Scand., 58: 457.PubMedCrossRefGoogle Scholar
  25. López-Ibor Aliflo, J.J., Ayuso Gutierrez, J.L., and Montejo Iglesias, M.L., 1973, Tryptophan and amitriptyline in the treatment of depression: a double-blind study, Int. Pharmacopsychiat., 8: 145.Google Scholar
  26. Madras, B.K., and Sourkes, T.L., 1968, Effects of drugs on the metabolism of tryptophan: alpha-hydrazinotryptophan and other amino acid analogs, Biochem. Pharmacol., 17: 1037.PubMedCrossRefGoogle Scholar
  27. Miller, S.E., Kirk, L., and Fremming, K.H., 1976, Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan, Psychopharmacol., 49: 205.CrossRefGoogle Scholar
  28. Murphy, D.L., Baker, M., Goodwin, F.K., Miller, H., Kotin,J., and Bunney, W.E., 1974, L-Tryptophan in affective disorders: indoleamine changes and differential clinical effects, Psychopharmacol., 34: 11.CrossRefGoogle Scholar
  29. Murphy, D.L., Campbell, I.C., and Costa, J.L., 1978, The brain serotonergic system in the affective disorders, Prog. NeuroPsychopharmac., 2: 1.CrossRefGoogle Scholar
  30. Pare, C.M.B., 1963, Potentiation of monoamine oxidase inhibitors by tryptophan, Lancet, ii: 527.CrossRefGoogle Scholar
  31. Poitou, P., and Boulu, R., 1977, Psychopharmacologie du tryptophane, Path. Biol., 25: 565.Google Scholar
  32. Shaw, D.M., MacSweeney, D.A., Hewland, R., and Johnson, A.L., 1975, Tricyclic antidepressants and tryptophan in unipolar depression, Psychol. Med., 5: 276.PubMedCrossRefGoogle Scholar
  33. Sheard, M.H., Zolovick, A., and Aghajanian, G.K., 1972, Raphe neurons: effect of tricyclic antidepressant drugs, Brain Res., 43: 690.PubMedCrossRefGoogle Scholar
  34. Shopsin, B., 1978, Enhancement of the antidepressant response to L-tryptophan by a liver pyrrolase inhibitor: a rational treatment approach, Neuropsychobiol., 4: 188.CrossRefGoogle Scholar
  35. Ternaux, J.P., Boireau, A., Bourgoin, S. Hamon, M., Hery, F., and Glowinski, J., 1976, In vivo release of 5HT in the lateral ventricle of the rat: effects of 5-hydroxytryptophan and tryptophan, Brain Res., 101: 533.Google Scholar
  36. Trulson, M.E., and Jacobs, B.L., 1976, Dose-response relationships between systemically administered L-tryptophan or L-5-hydroxytryptophan and raphe unit activity in the rat, Neuropharmacol., 15: 339.CrossRefGoogle Scholar
  37. van Praag, H.M., Flentge, F., Korf, J., Dols, L.C.W., and Schut, T., 1973, The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man, Psychopharmacol., 33: 141.CrossRefGoogle Scholar
  38. Walinder, J., Skott, A., Carlsson, A., Nagy, A., and Roos, B.E., 1976, Potentiation of the antidepressant action of clomipramine by tryptophan, Arch. Gen. Psychiat., 33: 1384.PubMedCrossRefGoogle Scholar
  39. Winston, F., 1975, Treatment of unipola~ depression, Lancet, ii: 868.CrossRefGoogle Scholar
  40. Wirz-Justice, A., 1977, Theoretical and therapeutic potential of indoleamine precursors, Neuropsychobiol., 3: 199.CrossRefGoogle Scholar
  41. Wolf, H., 1973, Studies on tryptophan metabolism in man, Scand. Scand.J. Clin. Lab. Invest., supplement 136: 1Google Scholar
  42. Young, S.N., and Sourkes, T.L., 1974, The antidepressant action of tryptophan, Lancet, ii: 897.CrossRefGoogle Scholar
  43. Young, S.N., and Sourkes, T.L., 1975, Tryptophan catabolism by tryptophan pyrrolase in rat liver: the effect of tryptophan loads and changes in tryptophan pyrrolase activity, J. Biol. Chem. 250: 5009.PubMedGoogle Scholar
  44. Young, S.N., and Sourkes, T.L., 1977, Tryptophan in the central nervous system: regulation and significance, in: “Advances in Neurochemistry, Vol. 2”, B.W. Agraroff and M.H. Aprison, eds., Springer Science+Business Media New York.Google Scholar
  45. Young, S.N., St-Arnaud-McKenzie, D., and Sourkes, T.L., 1978, The importance of aromatic amino acid decarboxylase and tryptophan pyrrolase in the catabolism of tryptophan, Biochem. Pharmacol., 27: 763.PubMedCrossRefGoogle Scholar
  46. Young, S.N., Anderson, G.M., Gauthier, S., and Purdy, W.C., 1979, The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid, J. Neurochem., in press.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Simon N. Young
    • 1
    • 2
  • Guy Chouinard
    • 1
    • 2
  • Lawrence Annable
    • 1
    • 2
  1. 1.Department of PsychiatryMcGill UniversityMontrealCanada
  2. 2.Research DepartmentHôpital Louis-H. LafontaineMontrealCanada

Personalised recommendations